Lataa...
Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment
BACKGROUND: Bortezomib is a proteasome inhibitor with minimal clinical activity as a monotherapy in solid tumours, but its combination with other targeted therapies is being actively investigated as a way to increase its anticarcinogenic properties. Here, we evaluate the therapeutic potential of co-...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3261668/ https://ncbi.nlm.nih.gov/pubmed/22166800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.546 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|